BioGaia

The number of shares and votes in BioGaia AB (publ) increased in August due to the exercise of some warrants issued under the BioGaia incentive program 2021/2024 for subscription of shares. Through this subscription, the number of Class B shares and votes in BioGaia increased by 140,000 and the share capital increased by SEK 28,000.

As of August 30, 2024, the total number of shares in BioGaia amounts to 101,157,310 of which 3,703,340 are Class A shares with ten votes each and 97,453,970 are Class B shares with one vote each, totaling 134,487,370 votes. Additionally, the share capital amounts to SEK 20,231,462.

As of August 30, 2024, BioGaia holds no treasury shares.

Follow us:
Subscribe to BioGaia press releases here
LinkedIn here

Contacts:
Alexander Kotsinas, CFO
Email: alexander.kotsinas@biogaia.com
Phone: +46 735 00 11 11

Mikaela Idermark Stern, Corporate Communications
Email: mikaela.idermark.stern@biogaia.com
Phone: +46 730 95 61 50

About BioGaia
BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaiagroup.com

This disclosure contains information that BioGaia is obliged to make public pursuant to the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact person, on 30-08-2024 at 11:00 CEST.